YCYusuf Ziya Colak

Yusuf Ziya Colak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yusuf Ziya Colak has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The Microbial Face of Type 2 Diabetes: The Role of Gut Microbiota and Therapeutic Potential

    by Aylin Çolak, Hüseyin Kahraman, Yusuf Ziya Çolak

    Metabolic diseases, such as diabetes and obesity, constitute significant public health challenges on a global scale. Among these conditions, diabetes emerges as one of the most widespread and impactful diseases of the modern era. Accumulating evidence shows that diabetes is major contributing factor to the development of several life-threatening complications. Recently, the human microbiome has garnered increased attention for its role in the pathophysiology of Diabetes Mellitus. Innovations in high-throughput sequencing technologies have enabled profiling of the gut microbiota, revealing their critical roles in metabolic regulation. Specifically, these microbial communities are implicated in modulating glucose and lipid metabolism, as well as adipose tissue function. Many research groups suggest that targeting the gut microbiota may provide inovatife therapeutic avenues for diabetes management. This review aims to elucidate the interplay between gut microbial composition and the pathogenesis of Type 2 Diabetes Mellitus.

  • Open Access

    Effects of Sugammadex on the Coagulation Profile of Living Liver Donors Undergoing Hepatectomy: A Case-Control Study

    by Duygu Demiroz, Yusuf Ziya Colak, Sami Akbulut, Oya Olcay Ozdes, Muharrem Ucar, Mehmet Ali Erdogan, Serdar Karakas, Nurcin Gulhas

    Background: The most important concern regarding living donor liver transplantation is the safety of living liver donors, of which anesthesia management is an important part. Sugammadex, which has recently been used frequently for the reversal of neuromuscular blockade, is known to cause adverse effects on the coagulation profile. This study seeks to assess the impact of neostigmine and sugammadex on coagulation parameters in living liver donors following hepatectomy. Methods: We compared the demographic, clinical, and coagulation parameters of 209 living liver donors who received sugammadex (2 mg/kg) for neuromuscular blockade reversal during donor hepatectomy procedures from January 2018 to July 2022, with 209 patients who received neostigmine (50 g/kg) for the same purpose during the same timeframe. We compared the following parameters: age, gender, prothrombin time (PT), partial thromboplastin time (PTT), international normalized ratio (INR), hemoglobin (Hb), platelet count, ICU stay, hospital stay, and relaparotomy for bleeding and other causes. Results: Demographic data and preoperative biochemical values were similar in both groups. PT (p = 0.004) and aPTT (p < 0.001) values were significantly longer in the postoperative period in both groups; the difference between preoperative and postoperative PT (p = 0.009) and aPTT (p < 0.001) was significantly higher in the sugammadex group. However, neither group showed any elongation beyond the reference range. The sugammadex group had an elevated postoperative platelet count (p = 0.040). The duration of patients’ stay in the ICU was significantly shorter in the sugammadex group (p < 0.001). Conclusion: The prolonged aPTT and PT associated with sugammadex did not lead to any postoperative bleeding complications. The sugammadex group significantly reduced the duration of ICU stays, while the hospital stays remained comparable. Further multicentric prospective randomized studies should support our study’s findings, which demonstrate the safe use of low-dose sugammadex.


  • Open Access

    Living Liver Donor Paired Exchange: Can Anaesthesia Management Challenge?

    by Mehmet Ali Erdoğan, Muharrem Uçar, Yusuf Ziya Çolak, Duygu Demiröz, Oya Olcay Özdeş

    Living Liver Donor Paired Exchange: Can Anaesthesia Management Challenge? - Turkish Journal of Anaesthesiology and Reanimation


  • Can Preoperative Parameters of Inflammation be Used to Predict Acute Kidney Injury in Pediatric Liver Transplant Recipients? A Single-Center Retrospective Study

    by Duygu Demiröz, Oya Olcay Özdeş, Yusuf Ziya Çolak, Mehmet Ali Erdoğan, Tuğçe Gazioğlu, Serdar Karakaş, Sevgi Demiröz Taşolar, Neslihan Altunkaya Yağcı, Nurçin Gülhas

    Can Preoperative Parameters of Inflammation be Used to Predict Acute Kidney Injury in Pediatric Liver Transplant Recipients? A Single-Center Retrospective Study - Istanbul Medical Journal


  • Open Access

    Incidence and Risk Factors of Acute Kidney Injury in Pediatric Liver Transplant Patients: A Retrospective Study

    by Duygu Demiroz, Yusuf Ziya Colak, Oya Olcay Ozdes, Muharrem Ucar, Mehmet Ali Erdogan, Hüseyin Ilksen Toprak, Serdar Karakas, Sevgi Demiroz Tasolar, Cemalettin Aydın, Ilknur Varol

    Acute kidney injury (AKI) significantly contributes to the mortality and morbidity rates among pediatric liver transplant (LT) recipients. Our study aimed to assess the potential factors contributing to AKI in pediatric LT patients and to analyze the impact of AKI on postoperative mortality and hospitalization duration. About 235 pediatric LT patients under the age of 18 between the years 2015 and 2021 were evaluated retrospectively. The relationship between preoperative and intraoperative variables of the patients and AKI developed when the early postoperatıve period was assessed. A correlation was found between the patients’ preoperative age, albumin levels, and AKI. AKI was found to be associated with the duration of surgery and intraoperative blood transfusion. Our findings revealed that the severity of AKI in pediatric LT patients is linked to extended surgical durations and increased blood transfusions resulting from hemodynamically compromised blood loss. Furthermore, independent risk factors for AKI were identified as prolonged warm ischemia and the overall duration of the operation. Demiroz D, Colak YZ, Ozdes OO, Ucar M, Ali Erdogan M, Toprak HI, et al. Incidence and Risk Factors of Acute Kidney İnjury in Pediatric Liver Transplant Patients: A Retrospective Study. Indian J Crit Care Med 2024;28(1):75–79.


  • Open Access

    Does Rocuroinum Dose Adjusted Due to Lean Body Weight Provide Adequate Intubation Conditions?: A Prospective Observational Study

    by Duygu Demiroz, Yusuf Ziya Colak, Sumeyye Koc Iclek, Mehmet Ali Erdogan, Neslihan Altunkaya Yagci, Mahmut Durmus, Nurcın Gulhas

    Introduction and Aim. There is no consensus on the weight parameters to use when titrating the dosage of the neuromuscular blocking agents during intubation. In our study, we administered rocuronium, based on either the lean body weight (LBW) or the total body weight in patients with body mass index (BMI) of 18.5 to 34.9 and compared the duration of action of the drug and its effects on tracheal intubation conditions and hemodynamic parameters. Methods. This is a prospective, observational study. Patients between the ages of 18 and 65 with BMI of 18.5–34.9, who are expected to be under general anesthesia for less than 6 hours, were divided into 3 groups according to their BMI (Group 1 BMI = 18.5–24.9, Group 2 BMI = 25–29.9, Group 3 BMI = 30–34.9). These groups were randomly divided into 2 subgroups: Groups LBW; 1 LBW, 2 LBW, and 3 LBW were given rocuronium intubation dosages based on their LBW while control groups; 1K, 2K, and 3K were given 0.6 mg/kg rocuronium according to their total body weight. The data on the duration of action of rocuronium and its effects on the endotracheal intubation conditions were evaluated. Results. In Group 1, T1 time was found to be significantly longer (p = 0.001). Intubation score and the use of additional rocuronium dose were found to be significantly higher in Group 1 LBW than in Group 1K (p = 0.001). In Group 1, an additional rocuronium dose was needed to achieve optimal intubation conditions for subgroup 1 LBW. Rocuronium duration of action was found to be significantly longer in control groups 2 and 3, that received TBW‐based dosage. Conclusion. In adult patients with a BMI of 18.5 and 24.9 BMI, we report optimal intubation conditions with the LBW‐adjusted rocuronium dosage. This trial is registered with NCT05476952.


  • Open Access

    Feasibility, safety, and economic consequences of using minimal flow anaesthesia by Maquet FLOW-i equipped with automated gas control

    by Yusuf Z. Colak, Hüseyin I. Toprak

    Low fresh gas flow rates are recommended because of their benefits, however, its use is limited due to associated risks. The main purpose of this study was to investigate whether 300 mL of fresh gas flow that practised with automated gas control mode is applicable and safe. The second aim is to show that automated mode can provide economic benefits. Sixty hepatectomy cases who suitable criterias were included to cohort study in three groups as prospective, sequential, observational. An operating room were allocated only for this study. 300 mL fresh gas flow with automated mode (groupA3), 600 mL fresh gas flow with automated mode (groupA6) and, 600 mL fresh gas flow with manually (groupM6) was applied. Patients’ respiratory, hemodynamic parameters (safety), number of setting changes, O2concentration in the flowmeter that maintained FiO2:0.4 during the low flow anaesthesia (feasibility) and comsumption data of anaesthetic agent and CO2absorber (economical) were collected and compared. p < 0.05 was accepted as statistical significance level. No significant differences were detected between the groups in terms of demographic data and duration of operation. Safety datas (hemodynamic, respiratory, and tissue perfusion parameters) were within normal limits in all patients. O2concentration in the flowmeter that maintained FiO2:0.4 was statistically higher in groupA3 (92%) than other groups (p < 0.001) but it was still within applicable limits (below the 100%). Number of setting changes was statistically higher in groupM6 than other groups (p < 0.001). The anaesthetic agent consumption was statistically less in groupA3 (p = 0.018). We performed fresh gas flow of 300 mL by automated mode without deviating from the safety limits and reduced the consumption of anaesthetic agent. We were able to maintain FiO2:0.4 in hepatectomies without much setting changes, and we think that the automated mode is better in terms of ease of practise.


  • Feasibility, safety, and economic consequences of using low flow anesthesia according to body weight

    by Yusuf Z. Colak, Hüseyin I. Toprak

    Background Low flow anesthesia (LFA) provides a saving up to 75% and improves the dynamics of inhaled anesthesia gas, increases mucociliary clearance, maintains body temperature, and reduces water loss. LFA has been recommended for anesthesiologists in recent years to avoid high fresh gas flow (FGF). However, LFA use is limited due to associated risks. The main purpose of this study was to investigate whether LFA according to body weight, which is the main determinant of oxygen requirement, is feasible and safe in the normoxia range. The second aim was to show that this method can provide economic benefit. Methods Eighty donor hepatectomy cases were included to study in two groups as prospective, observational. A surgery room and a team were allocated only for this study. Considering the oxygen requirement (approximately 3–3.5 mL/kg/min), for the first 40 cases, 10 mL/kg (group 10) FGF was applied; for the second 40 cases, 20 mL/kg (group 20) was applied. Desflurane (Suprane©) was used as an inhalation agent, and analgesia was achieved with remifentanil infusion. Patients’ demographic, respiratory, hemodynamic, and tissue perfusion parameters (SpO2 and NIRS), and comsumption data (anesthetic agent and CO2 absorbent) were collected and compared. Results No significant differences were detected between the groups in terms of demographic data, duration of surgery, and hemodynamic, respiratory, and tissue perfusion parameters. These parameters were within normal limits in all patients at all times. The maximum O2 concentration in the FGF that maintained FiO2:0.4 and provided adequate oxygenation during the LFA was 61% (min 56%; max 67%) in group 10, and 47% (min 43%; max 51%) in group 20. The hourly anesthetic agent consumption was significantly different in group 10 than in group 20 (12.4 ± 4 mL vs. 21.5 ± 8 mL/h, respectively (p < 0.001). Conclusions We performed 10 mL/kg FGF speed without deviating from the safety limits to be FiO2:0.4 in donor hepatectomies, reducing the total costs 38% compared with 20 mL/kg FGF.


  • Multiple Sklerozlu Gebede Anestezi Yönetimi

    by Yusuf Çolak, Ferda Yaman

    Multiple skleroz (MS), genetik faktörlerin de önemli oranda rol aldığı çoğunlukla kadın hastaların etkilendiği yaygın olarak gözlenmekte olan santral sinir sisteminin immun-demiyenilizan hastalığıdır. Stress, cerrahi, anestezi, emosyonel sıkıntı, vücut ısısı değişiklikleri MS semptomlarında artmaya ve remisyondaki hastada yeni ataklara yol açabilir. Gebelik döneminde son trimesterda regresyon gösterdiği bununla birlikte gebelikten sonraki 3 ayda atakların belirgin arttığı bilinmektedir. Spinal anestezi, olasılıkla lokal anesteziklerin demiyelinizan nöronlara karşı artmış nörotoksik etkilerine bağlı olarak hastalığın postoperatif alevlenmesi neden olur. MS’de nöral dokudaki demiyelinizasyon spinal kordu lokal anesteziklerin histotoksik etkisine daha hassas hale getirir, bu yüzden spinal anestezinin kontrendike olduğunu bildiren yayınlar mevcutken spinal ve epidural anestezinin rölatif kontrendikasyon oluşturduğunu bildiren yayınlar da mevcuttur. Genel anestezi uygulamalarında kas gevşetici ilaçlar dikkatli kullanılmalıdır. Bu olguda elektif koşullarda sezaryen operasyonu planlanmış 26 yaşında MS hastası 38 haftalık nullipar gebe ve anestezik yaklaşımı literatür eşliğinde sunmayı amaçladık. Hastaya ameliyat, anestezi yöntemi ve riskler açıklandıktan sonra genel anestezi uygulamasına karar verildi. Kas gevşeticisiz entübasyon planlanmış olup propofole bağlı şiddetli ve yaygın myoklonik kasılmalar gözlenmiş olan olguda düşük doz kas gevşetici uygulanarak komplikasyonsuz entübasyon gerçekleştirildi. Anestezi idamesi sevofluran beraberinde remifentanil infüzyon ile sağlandı. Hastanın vücut ısı monitorizasyonu postoperatif 24 saat boyunca takip edildi. Postoperatif 4 hafta boyunca MS atak benzeri semptomlara rastlanmadı.